NAD+ (the oxidized from of nicotinamide adenine dinucleotide) is critical to cellular health and energy.

That’s because NAD+ is essential to mitochondrial health, specifically enabling the cell to do two things:

• Produce energy

• Activate cellular repair mechanisms

But… NAD+ declines significantly with age, halving every 20 years.  This impairs the cell’s ability to generate energy and repair damage and, ultimately, leads to the physical signs and conditions associated with aging.

NAD+ has, therefore, become an important target for healthy aging

However, the biology associated with NAD+ production is complex and involves a number of proteins, enzymes and pathways that interconnect and influence each other. So, there are limitations in targeting one specific area of the body’s ability to produce NAD+; it requires a multitargeted approach that considers the whole system.

Nuchido TIME+ was developed by a team of systems pharmacologists, specialists in understanding whole biological networks and identifying the most efficient ways to influence them.  Nuchido TIME+ goes beyond a single target such as a precursor like NR or NMN and, instead, provides a whole system approach to improving the cell’s fundamental and youthful ability to make NAD+.